STAT3 and breast carcinoma: Another inhibitor, I157172, decreases the growth, proliferation, and migration rates of MCF7 breast cancer cells in a dose‐dependent manner via sirt1‐mediated STAT3 deacetylation (Wang, Shi, Zhang, et al. 2019).